MONASH IVF GROUP LIMITED — Director's Dealing 2024

Dec 3, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Monash IVF Group Limited ABN 90 169 302 309

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Michael Damian Knaap
Date of last notice	18 September 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	3 December 2024
No. of securities held prior to change	Direct interest of 734,642 Ordinary Shares Indirect interest of 150,655 Ordinary Shares held by MKN Family Holdings Pty Ltd as trustee for the Pakhill Superannuation Fund Performance Rights: • 532,599 under the 2023 Equity Incentive Plan • 517,433 under the 2024 Equity Incentive Plan
Class	Performance Rights
Number acquired	614,447 Performance Rights

L\355757801.1

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change	Direct interest of 734,642 Ordinary Shares Indirect interest of 150,655 Ordinary Shares held by MKN Family Holdings Pty Ltd as trustee for the Pakhill Superannuation Fund Performance Rights: • 532,599 under the 2023 Equity Incentive Plan • 517,433 under the 2024 Equity Incentive Plan • 552,782 under the 2025 Equity Incentive Plan • 61,665 as a deferral of 20% of Mr Knaap’s short term incentive for FY2024
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of 552,782 Performance Rights as approved at the 2024 Annual General Meeting. Issue of 61,665 Performance Rights as a deferral of 20% of Mr Knaap’s short term incentive for FY2024. The ordinary shares to be acquired in satisfaction of these Performance Rights are required to be purchased on-market.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A

L\355757801.1

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	N/A
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

L\355757801.1

01/01/2011 Appendix 3Y Page 3